<document>
 <table id="Table 1">
  <caption text="

         Coronary Vasomotion Disorders International Study (COVADIS) clinical criteria for the diagnosis of microvascular angina.
        
">
  </caption>
  <row row="0">
   <cell col-end="1" col-start="0" row-end="0" row-start="0" text="COVADIS criteria for microvascular angina">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
   </cell>
  </row>
  <row row="1">
   <cell col-end="0" col-start="0" row-end="1" row-start="1" text="1. Symptoms of myocardial ischemia">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
   </cell>
   <cell col-end="1" col-start="1" row-end="1" row-start="1" text="•
             

              Effort and/or rest angina
             



              •
             

              Angina equivalents (i.e. shortness of breath)">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
   </cell>
  </row>
  <row row="2">
   <cell col-end="0" col-start="0" row-end="2" row-start="2" text="2. Absence of obstructive CAD (&gt;50% diameter reduction and/or FFR &lt;0.80) by either:">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
   </cell>
   <cell col-end="1" col-start="1" row-end="2" row-start="2" text="•
             

              CT coronary angiography (CTCA)
             



              •
             

              Invasive coronary angiography">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
   </cell>
  </row>
  <row row="3">
   <cell col-end="0" col-start="0" row-end="3" row-start="3" text="3. Objective evidence of myocardial ischemia">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
   </cell>
   <cell col-end="1" col-start="1" row-end="3" row-start="3" text="•
             

              Ischemic ECG changes during an episode of chest pain
             



              •
             

              Stress-induced chest pain and/or ischemic ECG changes in the presence of transient/reversible abnormal myocardial perfusion and/or wall motion abnormality">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
   </cell>
  </row>
  <row row="4">
   <cell col-end="0" col-start="0" row-end="4" row-start="4" text="4. Evidence of impaired coronary microvascular function">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
   </cell>
   <cell col-end="1" col-start="1" row-end="4" row-start="4" text="•
             

              Impaired coronary flow reserve (cut-off values depending on methodology use between ≤2.0 and
              
              ≤
              
              2.5)
             



              •
             

              Coronary microvascular spasm, defined as reproduction of symptoms, ischemic ECG shifts but no epicardial spasm during acetylcholine testing.
             



              •
             

              Abnormal coronary microvascular resistance indices (e.g. IMR &gt;25, HMR ≥2.5
              
              mm Hg·cm-1·s) (69)
             



              •
             

              Coronary slow flow phenomenon">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
   </cell>
  </row>
  <statements>
   <statement id="0" text="The value • CT coronary angiography (CTCA) • Invasive coronary angiography belongs to covadis criteria for microvascular angina" type="">
   </statement>
   <statement id="1" text="• Effort and/or rest angina • Angina equivalents (i.e. shortness of breath) is in covadis criteria for microvascular angina" type="">
   </statement>
   <statement id="2" text="• Impaired coronary flow reserve (cut-off values depending on methodology use between ≤2.0 and ≤ 2.5) • Coronary microvascular spasm, defined as reproduction of symptoms, ischemic ECG shifts but no epicardial spasm during acetylcholine testing. • Abnormal coronary microvascular resistance indices (e.g. IMR &gt;25, HMR ≥2.5 mm Hg·cm-1·s) (69) • Coronary slow flow phenomenon is in covadis criteria for microvascular angina" type="">
   </statement>
   <statement id="3" text="The value • Ischemic ECG changes during an episode of chest pain • Stress-induced chest pain and/or ischemic ECG changes in the presence of transient/reversible abnormal myocardial perfusion and/or wall motion abnormality belongs to covadis criteria for microvascular angina" type="">
   </statement>
   <statement id="4" text="There are no duplicate values in covadis criteria for microvascular angina" type="">
   </statement>
   <statement id="5" text="Covadis criteria for microvascular angina always has the same value." type="">
   </statement>
  </statements>
 </table>
</document>
